Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillation.

about

Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillation.

Item

http://www.wikidata.org/entity/Q38084943

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cost effectiveness of antiarrh ...... ring from atrial fibrillation.

@en

type

Item

label

Cost effectiveness of antiarrh ...... ring from atrial fibrillation.

@en

prefLabel

Cost effectiveness of antiarrh ...... ring from atrial fibrillation.

@en

P1476

Cost effectiveness of antiarrh ...... ring from atrial fibrillation.

@en

P2093

Bernd Brüggenjürgen

http://www.w3.org/2001/XMLSchema#string

Nadja Ezzat

http://www.w3.org/2001/XMLSchema#string

Stefan Kohler

http://www.w3.org/2001/XMLSchema#string

Stefan N Willich

http://www.w3.org/2001/XMLSchema#string

Thomas Reinhold

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation.

The costs of atrial fibrillation in patients with cardiovascular comorbidities--a longitudinal analysis of German health insurance data.

A comparison of rate control and rhythm control in patients with atrial fibrillation.

Rising rates of hospital admissions for atrial fibrillation.

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study.

Atrial fibrillation: the cost of illness in Sweden

P2888

s40273-013-0028-7

P304

195-213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40273-013-0028-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235741262

http://www.w3.org/2001/XMLSchema#string

P698

23444271

http://www.w3.org/2001/XMLSchema#string